Neuro-oncology and brain imaging
Clinical research includes patients with newly diagnosed cerebral gliomas, recurrent cerebral gliomas, and brain metastases, with attention to tumour assessment and tracer distribution in PET imaging.
- Glioma diagnosis
- Brain metastases
- FET PET
- Fluciclovine PET
Work in this area is linked to advanced imaging for central nervous system tumours and comparative evaluation of radiotracer uptake patterns.
Hepatology and intestinal microbiome disorders
Studies address cirrhosis and ascites, with a focus on immune activation and the therapeutic use of fecal microbiota transfer in chronic liver disease.
- Cirrhosis
- Ascites
- Immune activation
- Fecal microbiota transfer
This area reflects interest in the interaction between liver disease, systemic inflammation, and microbiome-based interventions.
Myeloproliferative neoplasms
Research includes patients with polycythemia vera and essential thrombocythemia, especially in higher-risk disease settings requiring targeted hematology care.
- Polycythemia vera
- Essential thrombocythemia
- Ruxolitinib
- Best available therapy
The sponsor is involved in clinical evaluation of treatment options for myeloproliferative disorders with emphasis on safety and disease control.
Sepsis and intra-abdominal infection
Trials examine secondary and quaternary peritonitis as well as sepsis, with outcomes related to multiple organ failure across the lung, heart, kidney, liver, and blood.
- Peritonitis
- Source control
- Multiple organ failure
- Critical care
These studies are centered on severe infectious disease and acute care settings requiring coordinated management of systemic complications.
